Literature DB >> 11174850

Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland.

G Pelletier1, V Luu-The, M El-Alfy, S Li, F Labrie.   

Abstract

The subcellular distribution of steroidogenic enzymes has so far been studied mostly in classical endocrine glands and in the placenta. In the peripheral intracrine organs which synthesize sex steroids there is no indication about the organelles which contain the enzymes involved in steroid biosynthesis. We have thus investigated the subcellular localization of two enzymes involved in the production of sex steroids, namely 3beta-hydroxysteroid dehydrogenase (3beta-HSD) and type 5 17beta-hydroxysteroid dehydrogenase (17beta-HSD). Using specific antibodies to these enzymes, we conducted immunoelectron microscopic studies in two peripheral tissues, namely the human prostate and mammary gland. In the prostate, immunolabelling for both 3beta-HSD and type 5 17beta-HSD was detected in the basal cells of the tube-alveoli as well as in fibroblasts and endothelial cells lining the blood vessels. In all the labelled cell types, the gold particles were distributed throughout the cytoplasm. No obvious association with any specific organelle could be observed, although some concentration of gold particles was occasionally found over bundles of microfilaments. In mammary gland sections immunolabelled for 3beta-HSD or type 5 17beta-HSD localization, labelling was observed in the cytoplasm of the secretory epithelial cells in both the acini and terminal ducts. Immunolabelling was also found in the endothelial cells as well as in fibroblasts in stroma and blood vessels. The gold particles were not detected over any organelles, except with the occasional accumulation of gold particles over microfilaments. The present data on the localization of two steroidogenic enzymes leading to the synthesis of testosterone indicate that these enzymes are located not only in epithelial cells but also in stromal and endothelial cells in both tissues studied. The absence of any association of the enzymes with membrane-bound organelles appears as a common finding in the reactive cell types of two peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11174850     DOI: 10.1677/jme.0.0260011

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  12 in total

1.  Chinese red yeast rice inhibition of prostate tumor growth in SCID mice.

Authors:  Mee Young Hong; Susanne Henning; Aune Moro; Navindra P Seeram; Yanjun Zhang; David Heber
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-28

2.  Transforming growth factor β1 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells.

Authors:  Xunxian Liu; Yun-Shang Piao; Julia T Arnold
Journal:  Carcinogenesis       Date:  2011-09-12       Impact factor: 4.944

3.  Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.

Authors:  Caroline H Diep; Hannah Ahrendt; Carol A Lange
Journal:  Steroids       Date:  2016-09-15       Impact factor: 2.668

Review 4.  The current evidence on statin use and prostate cancer prevention: are we there yet?

Authors:  Mahmoud A Alfaqih; Emma H Allott; Robert J Hamilton; Michael R Freeman; Stephen J Freedland
Journal:  Nat Rev Urol       Date:  2016-10-25       Impact factor: 14.432

5.  Endocrinological Roles for Testosterone in Resistance Exercise Responses and Adaptations.

Authors:  David R Hooper; William J Kraemer; Brian C Focht; Jeff S Volek; William H DuPont; Lydia K Caldwell; Carl M Maresh
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

6.  The Role of Androgens in Normal and Malignant Breast Tissue.

Authors:  Katharina Tiefenbacher; Günter Daxenbichler
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

Review 7.  Rationale for statins in the chemoprevention of prostate cancer.

Authors:  Robert J Hamilton; Stephen J Freedland
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

Review 8.  Steroid hormone transforming aldo-keto reductases and cancer.

Authors:  Trevor M Penning; Michael C Byrns
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

Review 9.  Evidence on Statins, Omega-3, and Prostate Cancer: A Narrative Review.

Authors:  Hwanik Kim; Jung Kwon Kim
Journal:  World J Mens Health       Date:  2022-01-01       Impact factor: 6.494

10.  Adrenal hypoplasia congenita presenting as congenital adrenal hyperplasia.

Authors:  Jennifer L Flint; Jill D Jacobson
Journal:  Case Rep Endocrinol       Date:  2013-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.